Bischof competitive analysis

Explore patent oppositions filed by Bischof against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 30, 2026
Patent NumberTitleApplicantOpposition Date
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026
Single-Use Cell Culture Container With One Or More In-Situ Online SensorsF HOFFMANN LA ROCHEApr 2, 2025
Immunogenic Mutant Peptide Screening PlatformF HOFFMANN LA ROCHEApr 27, 2022
Vectors For Transgene ExpressionADAPTIMMUNEMar 18, 2020
Biological Inhibitors Of Ror1 Capable Of Inducing Cell DeathBIOINVENTFeb 5, 2018

Explore Bischof's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 30, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 2, 2019Flexible Packaging Container1

Latest PTAB cases involving Bischof

Discover the latest PTAB cases involving Bischof, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bischof with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 30, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BISCHOF1 - - -
BIOINVENT - 2 - -
KANCERA - 2 - -